Understanding Stem Cells
Stem cells are the very foundation of life—the body’s most primitive cells with extraordinary regenerative and differentiating abilities. They are the driving force behind daily organ function, tissue renewal, and repair, making them indispensable for sustaining health and vitality.
Hematopoietic Stem Cells
Hematopoietic Stem Cells (HSCs) are the body’s factory for producing blood and immune system components. Umbilical cord blood from newborns contains a rich supply of hematopoietic stem cells, capable of generating healthy blood cells and immune cells. Clinically, they are applied in the treatment of blood, immune, and metabolic disorders.
Mesenchymal Stem Cells
Mesenchymal Stem Cells (MSCs) possess strong abilities for multi-lineage differentiation and proliferation. They can differentiate into specialized cells such as bone, nerve, and muscle. Clinically, MSCs are widely used in cellular, neural, and tissue regeneration and repair, making them a vital resource for future regenerative medicine applications.
寶帶來的珍貴禮物－新生兒幹細胞
一次儲存，一生守護
新生兒幹細胞是最純淨、高活性的幹細胞來源。
生產後可立即由臍帶血、羊膜、臍帶、胎盤、羊水採集，安全無侵入性。
寶寶一生一次帶來世上的珍寶，可成為寶寶自己及全家人一生的健康守護。
造血幹細胞/臍帶血
造血幹細胞/臍帶血
間質幹細胞/臍帶
間質幹細胞/臍帶
間質幹細胞/羊膜
間質幹細胞/羊膜
間質幹細胞/胎盤
間質幹細胞/胎盤
間質幹細胞/胎盤
間質幹細胞/羊水
臍帶血，守護孩子成長期的關鍵
自1988年至今，全球已有超過40,000件臍帶血移植案例。
臨床應用上，台灣衛福部核准臍帶血的29項疾病治療，可望成為血液、免疫、惡性腫瘤及代謝異常等疾病的主要治療方式之一。
針對兒童期的疾病，臍帶血造血幹細胞是非常重要的醫療資源。特別是兒童常見四大癌症：白血病、腦瘤、惡性淋巴瘤、神經母細胞瘤，國內外都有臍帶血成功移植案例。
兒童腦性麻痺、腦傷與自閉症：美國杜克醫學中心喬安.庫茲伯博士 (Dr. Joanne Kurtzberg)，積極針對兒童腦麻、腦傷與自閉症進行臍帶血臨床研究，得到令人振奮的結果，受試孩童在症狀改善評估上有明顯進步，且經安全性實驗證實，臍帶血回輸非常安全且耐受性極高。
40,000
件，全球案例
29
項，疾病治療
4
項，兒童常見癌症
臍帶血
Mesenchymal Stem Cells – A Vital Resource in Regenerative Medicine
According to statistics from the U.S. National Institutes of Health (NIH), the number of clinical studies involving mesenchymal stem cells has grown significantly—from 109 cases in 2010 to more than 493 cases today. This remarkable growth highlights the immense potential of mesenchymal stem cells in future medical applications.
Clinically, mesenchymal stem cells are primarily used to repair damaged or diseased cells and tissues in organs. Applications include type 1 diabetes, corneal injury, spinal cord injury, liver cirrhosis, stroke, Alzheimer’s disease, malignant tumors, Parkinson’s disease, and more.
Research has confirmed that newborn umbilical cord, amniotic membrane, and placenta contain mesenchymal stem cells of the highest quality and activity. Preserving them at birth provides a precious medical resource that can safeguard the health of the entire family in the years to come.
Adipose-Derived Mesenchymal Stem Cells in Transplantation Applications in Taiwan
Recognized by Taiwan’s Ministry of Health and Welfare in 2018, adipose-derived mesenchymal stem cells (AD-MSCs) have been officially included in six major categories of cell therapy under the special regulation framework. As a cutting-edge source for advanced regenerative treatments, AD-MSCs are paving the way for innovative clinical applications and are approved for use in four key indications:
Chronic or non-healing wounds persisting for more than six weeks
Large-area burns or post-traumatic skin injuries covering more than 20% of total body surface area
Subcutaneous and dermal tissue defects
Degenerative arthritis and cartilage defects
衛福部公告6大項細胞治療項目及適應症
儲存珍貴新生兒幹細胞，守護孩子的關鍵決定
你知道嗎？許多兒童常見的後天疾病，如：腦麻、腦傷、自閉症、癌症…等，往往是出生後才會發現，每年卻都有上千例新增案例，臨床證實可透過幹細胞來修復。若出生時有存下寶寶的幹細胞，一旦需要，就有一份立即可用的醫療資源，讓孩子在第一時間得到最及時的治療。
新生兒幹細胞一生只有一次機會，存下寶寶最珍貴的醫療資源，是守護孩子未來的關鍵決定。
幹細胞醫療應用大未來 超出你的想像多更多
選擇一家令人安心的幹細胞保存公司，存下珍貴的新生兒幹細胞，為產前必做的重要清單之一。
了解台灣首例自存自用臍帶血治療腦性麻痺案例
【再生緣細胞生技臍帶血王小弟案例】 母親0.1秒的決定，讓孩子的一生有了新的可能性。